Study to evaluate the impact of a cancer fighting drug on slowing neurodegenerative disease progression

This NPR article discusses how Nilotinib seems to work by eliminating toxic proteins that build up in the brains of people with Parkinson’s and Alzheimer’s. The drug seems to activate a mechanism in brain cells that acts like a sort of garbage disposal.  Read the entire article on NRP.

Currently Georgetown University is looking for participants for a randomized, double blind, placebo-controlled study to evaluate the impact of low doses of a cancer fighting drug on slowing the progression of neurodegenerative diseases. Learn more about the study.

NursePartners does not advocate for any specific type of medication.  Our holistic approach seeks to connect before providing care.  For clients with advanced forms of dementia, we explore different ways to say hello and communicate.

Our carepartners follow the Teepa Snow’s positive physical approach to dementia care.  Through extensive training, carepartners learn how to deescalate situations and build meaningful relationships with our clients.  We do not promote a purely medicated method for working with clients living with dementia.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.